Chemotherapy in patients with penile carcinoma

Urologia Internationalis

Volumn 82, Issue 1, 2009, Pages 1-7

  Protzel, C ^a   Hakenberg, O W ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Chemotherapy; Penile carcinoma

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; IFOSFAMIDE; IRINOTECAN; ISOTRETINOIN; METHOTREXATE; MITOMYCIN C; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ALOPECIA; ANEMIA; BLOOD TOXICITY; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DIARRHEA; DISTAL PARESTHESIA; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; HUMAN; INFECTION; INGUINAL LYMPH NODE; INTERSTITIAL PNEUMONIA; KIDNEY DISEASE; LUNG DISEASE; LUNG EMBOLISM; LUNG FIBROSIS; LUNG FUNCTION; LUNG TOXICITY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PALLIATIVE THERAPY; PENIS CARCINOMA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; REVIEW; SEPTICEMIA; SIDE EFFECT; SKIN TOXICITY; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; HUMANS; LYMPHATIC METASTASIS; MALE; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; PALLIATIVE CARE; PENILE NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 58849144242     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000176016     Document Type: Review

References (30)

1. Naumann CM, Filippow N, Seif C, van der Horst C, Roelver L, Braun PM, Jünemann KP, Portillo FJ: Penile carcinoma (pT1 G2): surveillance or inguinal lymph node dissection? Onkologie 2005;28:135-138.
2. Gagliano RG, Blumenstein BA, Crawford ED, Stephens RL, Coltman CA Jr, Costanzi JJ: cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study. J Urol 1989;141:66-67.
3. Ahmed T, Sklaroff R, Yagoda A: Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol 1984;132:465-468.
4. Ahmed T, Sklaroff R, Yagoda A: An appraisal of the efficacy of bleomycin in epidermoid carcinoma of the penis. Anticancer Res 1984;4:289-292.
5. Maiche AG: Adjuvant treatment using bleomycin in squamous cell carcinoma of penis: study of 19 cases. Br J Urol 1983;55:542-544.
6. Sklaroff RB, Yagoda A: Methotrexate in the treatment of penile carcinoma. Cancer 1980;45:214-216.
7. Sklaroff RB, Yagoda A: Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma. Cancer 1979;44:1563-1565.
8. Garnick MB, Skarin AT, Steele GD Jr: Metastatic carcinoma of the penis: complete remission after high dose methotrexate chemotherapy. J Urol 1979;122:265-266.
9. Hussein AM, Benedetto P, Sridhar KS: Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 1990;65:433-438.
10. Shammas FV, Ous S, Fossa SD: Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992;147:630-632.
11. Kattan J, Culine S, Droz JP, Fadel E, Court B, Perrin JL, Wibault P, Haie-Meder C: Penile cancer chemotherapy: twelve years' experience at Institut Gustave-Roussy. Urology 1993;42:559-562.
12. Mitropoulos D, Dimopoulos MA, Kiroudi-Voulgari A, Zervas A, Dimopoulos C, Logothetis CJ: Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinoma. J Urol 1994;152:1124-1126.
13. Skeel RT, Huang J, Manola J, Wilding G, Dreicer R, Walker P, Muggia F, Crawford ED, Dutcher JP, Loehrer PJ: A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893). Cancer Invest 2003;21:41-46.
14. Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA: Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 2007;177:1335-1338.
15. Joerger M, Warzinek T, Klaeser B, Kluckert JT, Schmid HP, Gillessen S: Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 2004;63:778-780.
16. Theodore C, Skoneczna I, Bodrogi I, Leahy M, Kerst JM, Collette L, Ven K, Marréaud S, Oliver RD;for the EORTC Genito-Urinary Tract Cancer Group: A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 2008;19:1304-1307.
17. Dexeus FH, Logothetis CJ, Sella A, Amato R, Kilbourn R, Fitz K, Striegel A: Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 1991;146:1284-1287.
18. Haas GP, Blumenstein BA, Gagliano RG, Russell CA, Rivkin SE, Culkin DJ, Wolf M, Crawford ED: Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999;161:1823-1825.
19. Hakenberg OW, Nippgen JB, Froehner M, Zastrow S, Wirth MP: Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 2006;98:1225-1227.
20. Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J: Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 1998;160:1770-1774.
21. Leijte JA, Kerst JM, Bais E, Antonini N, Horenblas S: Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 2007;52:488-494.
22. Pizzocaro G, Piva L: Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 1988;27:823-824.
23. Pizzocaro G, Nicolai N, Milani A: Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer. Eur Urol 2008, in press.
24. Roth AD, Berney CR, Rohner S, Allal AS, Morel P, Marti MC, Aapro MS, Alberto P: Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential. Br J Cancer 2000;83:1637-1642.
25. Huang XY, Kubota Y, Nakada T, Sasagawa I, Suzuki H, Ishigooka M: Intra-arterial infusion chemotherapy for penile carcinoma with deep inguinal lymph node metastasis. Urol Int 1999;62:245-248.
26. Pizzocaro G, Piva L, Bandieramonte G, Tana S: Up-to-date management of carcinoma of the penis. Eur Urol 1997;32:5-15.
27. Pizzocaro G, Piva L, Nicolai N: Treatment of lymphatic metastasis of squamous cell carcinoma of the penis: experience at the National Tumor Institute of Milan. Arch Ital Urol Androl 1996;68:169-172.
28. Culkin DJ, Beer TM: Advanced penile carcinoma. J Urol 2003;170:359-365.
29. Murdoch D: Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review. Curr Opin Oncol 2007;19:216-221.
30. Long HJ 3rd: Management of metastatic cervical cancer: review of the literature. J Clin Oncol 2007;25:2966-2974.